Found: 26
Select item for more details and to access through your institution.
Expert consensus for the management of advanced or metastatic pancreatic neuroendocrine and carcinoid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1099, doi. 10.1007/s00280-014-2642-2
- By:
- Publication type:
- Article
Safety and feasibility of S-1 adjuvant chemotherapy for pancreatic cancer in elderly patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1115, doi. 10.1007/s00280-015-2736-5
- By:
- Publication type:
- Article
DNA intercalative 4-butylaminopyrimido[4′,5′:4,5]thieno(2,3-b)quinoline induces cell cycle arrest and apoptosis in leukemia cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1121, doi. 10.1007/s00280-015-2735-6
- By:
- Publication type:
- Article
DNA intercalative 4-butylaminopyrimido[4',5':4,5]thieno(2,3-b)quinoline induces cell cycle arrest and apoptosis in leukemia cells.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Phase II study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1135, doi. 10.1007/s00280-015-2730-y
- By:
- Publication type:
- Article
Pharmacokinetic and pharmacodynamic profile of bendamustine and its metabolites.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1143, doi. 10.1007/s00280-015-2727-6
- By:
- Publication type:
- Article
A phase I study of resminostat in Japanese patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1155, doi. 10.1007/s00280-015-2741-8
- By:
- Publication type:
- Article
Determinants of the activities of antifolates delivered into cells by folate-receptor-mediated endocytosis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1163, doi. 10.1007/s00280-015-2733-8
- By:
- Publication type:
- Article
A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1175, doi. 10.1007/s00280-015-2732-9
- By:
- Publication type:
- Article
Randomized study of orally administered fluorinated pyrimidines (capecitabine versus S-1) in women with metastatic or recurrent breast cancer: Japan Breast Cancer Research Network 05 Trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1183, doi. 10.1007/s00280-015-2738-3
- By:
- Publication type:
- Article
Association of decreased mRNA expression of multidrug and toxin extrusion protein 1 in peripheral blood cells with the development of flutamide-induced liver injury.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1191, doi. 10.1007/s00280-015-2743-6
- By:
- Publication type:
- Article
Comparison of pharmacokinetics and safety of pegfilgrastim administered by two delivery methods: on-body injector and manual injection with a prefilled syringe.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1199, doi. 10.1007/s00280-015-2731-x
- By:
- Publication type:
- Article
Functional polymorphisms of ITGB1 are associated with clinical outcome of Chinese patients with resected colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1207, doi. 10.1007/s00280-015-2745-4
- By:
- Publication type:
- Article
Cisplatin resistance in human cervical, ovarian and lung cancer cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1217, doi. 10.1007/s00280-015-2739-2
- By:
- Publication type:
- Article
A phase II trial of gefitinib monotherapy in pretreated patients with advanced non-small cell lung cancer not harboring activating EGFR mutations: implications of sensitive EGFR mutation test.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1229, doi. 10.1007/s00280-015-2740-9
- By:
- Publication type:
- Article
Modulation of Regorafenib effects on HCC cell lines by epidermal growth factor.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1237, doi. 10.1007/s00280-015-2751-6
- By:
- Publication type:
- Article
Methylthioadenosine phosphorylase (MTAP)-deficient T-cell ALL xenografts are sensitive to pralatrexate and 6-thioguanine alone and in combination.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1247, doi. 10.1007/s00280-015-2747-2
- By:
- Publication type:
- Article
Inhibition of SN-38 glucuronidation by gefitinib and its metabolite.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1253, doi. 10.1007/s00280-015-2753-4
- By:
- Publication type:
- Article
High-dose erlotinib for refractory leptomeningeal metastases after failure of standard-dose EGFR-TKIs.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1261, doi. 10.1007/s00280-015-2759-y
- By:
- Publication type:
- Article
A phase II study of pemetrexed monotherapy in chemo-naïve Eastern Cooperative Oncology Group performance status 2 patients with EGFR wild-type or unknown advanced non-squamous non-small cell lung cancer (HANSHIN Oncology Group 002).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1267, doi. 10.1007/s00280-015-2755-2
- By:
- Publication type:
- Article
A phase II study of pemetrexed monotherapy in chemo-naïve Eastern Cooperative Oncology Group performance status 2 patients with EGFR wild-type or unknown advanced non-squamous non-small cell lung cancer (HANSHIN Oncology Group 002)
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Docetaxel in combination with octreotide shows synergistic apoptotic effect by increasing SSTR2 and SSTR5 expression levels in prostate and breast cancer cell lines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1273, doi. 10.1007/s00280-015-2756-1
- By:
- Publication type:
- Article
Phase II multicenter study of adjuvant S-1 for colorectal liver metastasis: survival analysis of N-SOG 01 trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1281, doi. 10.1007/s00280-015-2752-5
- By:
- Publication type:
- Article
PAI-1 and HER2 interaction in advanced breast cancer disease: evidence for added benefit from trastuzumab in HER2-negative patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1289, doi. 10.1007/s00280-015-2762-3
- By:
- Publication type:
- Article
The newly synthesized 2-arylnaphthyridin-4-one, CSC-3436, induces apoptosis of non-small cell lung cancer cells by inhibiting tubulin dynamics and activating CDK1.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1303, doi. 10.1007/s00280-015-2765-0
- By:
- Publication type:
- Article
Targeting the EWS-FLI1 transcription factor in Ewing sarcoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1317, doi. 10.1007/s00280-015-2726-7
- By:
- Publication type:
- Article